Document is current
Any future updates will be listed below
-
Authors
Lanfranchi, Francesco
Belgioia, Liliana
Vita, Daniele
Passoni, Jacopo
Mastrogiovanni, Sara
Catanoso, Alessandra
Sofia, Luca
Pau, Valentina
Raffa, Stefano
Chiola, Silvia
Donegani, Maria Isabella
Piva, Roberta
Riondato, Mattia
Marcenaro, Michela
Timon, Giorgia
Marini, Cecilia
Barra, Salvina
Sambuceti, Gianmario
Bauckneht, Matteo https://orcid.org/0000-0002-1937-9116
-
Funding
Funding for this research was provided by:
Università degli Studi di Genova (University Research Fund (FRA))
Università degli Studi di Genova
- License Information
-
More Information
Article History
Received: 3 August 2025
Accepted: 1 October 2025
First Online: 10 October 2025
Declarations
:
: M.B. reports personal fees for advisory board participation and speaker’s honoraria from Novartis, Bayer, Telix Pharmaceuticals, and Johnson & Johnson. All other authors report no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Local Ethics Committee (Regione Liguria Ethical Committee, registration number 5/2023–DB id 12914, date of approval 19-Jun-2023).
: The Local Ethical Committee (Regione Liguria Ethical Committee) waived informed consent due to the study’s retrospective design.
